Penserra Capital Management LLC Repare Therapeutics Inc. Transaction History

Penserra Capital Management LLC

  • $5.47 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$19.66 - $28.11 $16,711 - $23,893
-850 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$25.71 - $35.24 $257 - $352
10 Added 1.19%
850 $22,000
Q2 2021

Aug 12, 2021
BUY
$30.1 - $34.85 $301 - $348
10 Added 1.2%
840 $26,000
Q1 2021

May 13, 2021
SELL
$25.89 - $44.46 $388 - $666
-15 Reduced 1.78%
830 $25,000
Q4 2020

Feb 12, 2021
BUY
$23.42 - $39.5 $19,789 - $33,377
845 New
845 $28,000

Others Institutions Holding RPTX

# of Institutions
64
Shares Held
34.5M
Call Options Held
51K
Put Options Held
300
View Full List

About Repare Therapeutics Inc.

RPTX Quotes by TradingView
  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $53.3M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email